CN105622613B - 一种合成伊鲁替尼的方法 - Google Patents
一种合成伊鲁替尼的方法 Download PDFInfo
- Publication number
- CN105622613B CN105622613B CN201410648619.3A CN201410648619A CN105622613B CN 105622613 B CN105622613 B CN 105622613B CN 201410648619 A CN201410648619 A CN 201410648619A CN 105622613 B CN105622613 B CN 105622613B
- Authority
- CN
- China
- Prior art keywords
- compound
- formula
- reaction
- organic solvent
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410648619.3A CN105622613B (zh) | 2014-11-14 | 2014-11-14 | 一种合成伊鲁替尼的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410648619.3A CN105622613B (zh) | 2014-11-14 | 2014-11-14 | 一种合成伊鲁替尼的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105622613A CN105622613A (zh) | 2016-06-01 |
CN105622613B true CN105622613B (zh) | 2019-03-12 |
Family
ID=56037995
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410648619.3A Active CN105622613B (zh) | 2014-11-14 | 2014-11-14 | 一种合成伊鲁替尼的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105622613B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105294571B (zh) * | 2014-07-03 | 2019-04-23 | 浙江九洲药业股份有限公司 | 一种依鲁替尼中间体及其制备方法和用途 |
CN113929686B (zh) * | 2020-06-29 | 2023-08-22 | 鲁南制药集团股份有限公司 | 一种伊布替尼的制备方法 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1238343C (zh) * | 1999-09-09 | 2006-01-25 | 组合化学工业株式会社 | 嘧啶衍生物及含有该衍生物的除草剂 |
CN1926139A (zh) * | 2004-02-27 | 2007-03-07 | 霍夫曼-拉罗奇有限公司 | 稠合吡唑衍生物 |
CN1934111A (zh) * | 2004-02-27 | 2007-03-21 | 霍夫曼-拉罗奇有限公司 | 杂芳基稠合的吡唑并衍生物 |
CN103121999A (zh) * | 2012-08-29 | 2013-05-29 | 苏州迪飞医药科技有限公司 | 一种酪氨酸激酶抑制剂pci-32765的合成方法 |
US8673925B1 (en) * | 2013-04-09 | 2014-03-18 | Principia Biopharma Inc. | Tyrosine kinase inhibitors |
CN105294571A (zh) * | 2014-07-03 | 2016-02-03 | 浙江九洲药业股份有限公司 | 一种依鲁替尼中间体及其制备方法和用途 |
CN106795124A (zh) * | 2014-10-30 | 2017-05-31 | 桑多斯股份公司 | 取代的1H‑吡唑并[3,4‑d]嘧啶类化合物的合成 |
-
2014
- 2014-11-14 CN CN201410648619.3A patent/CN105622613B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1238343C (zh) * | 1999-09-09 | 2006-01-25 | 组合化学工业株式会社 | 嘧啶衍生物及含有该衍生物的除草剂 |
CN1926139A (zh) * | 2004-02-27 | 2007-03-07 | 霍夫曼-拉罗奇有限公司 | 稠合吡唑衍生物 |
CN1934111A (zh) * | 2004-02-27 | 2007-03-21 | 霍夫曼-拉罗奇有限公司 | 杂芳基稠合的吡唑并衍生物 |
CN103121999A (zh) * | 2012-08-29 | 2013-05-29 | 苏州迪飞医药科技有限公司 | 一种酪氨酸激酶抑制剂pci-32765的合成方法 |
US8673925B1 (en) * | 2013-04-09 | 2014-03-18 | Principia Biopharma Inc. | Tyrosine kinase inhibitors |
CN105294571A (zh) * | 2014-07-03 | 2016-02-03 | 浙江九洲药业股份有限公司 | 一种依鲁替尼中间体及其制备方法和用途 |
CN106795124A (zh) * | 2014-10-30 | 2017-05-31 | 桑多斯股份公司 | 取代的1H‑吡唑并[3,4‑d]嘧啶类化合物的合成 |
Non-Patent Citations (2)
Title |
---|
Pyrazoloheteroaryls: Novel p38a MAP kinase inhibiting scaffolds with oral activity;Laszlo Revesz et al.;《Bioorganic & Medicinal Chemistry Letters》;20051024;第16卷;第262-266页 |
Regio- and Chemoselective Metalation of Chloropyrimidine Derivatives with TMPMgCl·LiCl and TMP2Zn·2MgCl2·2LiCl;Marc Mosrin et al.;《Chem.Eur.J.》;20091229;第15卷;第1468-1477页 |
Also Published As
Publication number | Publication date |
---|---|
CN105622613A (zh) | 2016-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Mecadon et al. | L-Proline as an efficicent catalyst for the multi-component synthesis of 6-amino-4-alkyl/aryl-3-methyl-2, 4-dihydropyrano [2, 3-c] pyrazole-5-carbonitriles in water | |
US6143892A (en) | Process for making 5-substituted pyrazoles | |
Mecadon et al. | γ-Alumina as a recyclable catalyst for the four-component synthesis of 6-amino-4-alkyl/aryl-3-methyl-2, 4-dihydropyrano [2, 3-c] pyrazole-5-carbonitriles in aqueous medium | |
CN101977889B (zh) | 含氟酰基乙酸衍生物的制备方法、含氟吡唑甲酸酯衍生物的制备方法及含氟吡唑甲酸衍生物的制备方法 | |
KR101342184B1 (ko) | 사치환된 피리다진 헷지호그 경로 길항제 | |
TW201609696A (zh) | 用於製備3-(3-氯-1h-吡唑-1-基)吡啶的方法(三) | |
CZ225699A3 (cs) | Dusíkaté heteroaromatické sloučeniny jako inhibitory faktoru Xa | |
CN105622613B (zh) | 一种合成伊鲁替尼的方法 | |
WO2010122794A1 (ja) | ピラジンカルボン酸誘導体の製造方法及びその中間体 | |
CN103180308B (zh) | 制备苯并咪唑衍生物的方法 | |
US10858353B2 (en) | Intermediates useful for the synthesis of aminopyrimidine derivatives, process for preparing the same, and process for preparing aminopyrimidine derivatives using the same | |
JP6321889B2 (ja) | イブチニブ中間体化合物、その製造方法及び用途 | |
CN104507948A (zh) | 含氮杂环n-氧化物化合物的制造方法 | |
CN102300839B (zh) | 反式-{4-[(烷基氨基)甲基]环己基}乙酸酯的制备方法 | |
JP2009504721A (ja) | 化学工程 | |
WO2017186624A1 (en) | Process for the preparation of herbicidal pyridinylimidazolone compounds | |
JP4061333B2 (ja) | 2−(ピラゾール−1−イル)ピリジン誘導体 | |
CN110498808B (zh) | 一种合成(2s,3r)-3-取代苯基吡咯烷-2-羧酸的中间体及其制备方法和应用 | |
JP7429236B2 (ja) | ホステムサビルの調製方法 | |
KR101005834B1 (ko) | 피라졸의 제조방법 | |
Hormi Mecadon et al. | L-Proline as an efficicent catalyst for the multi-component synthesis of 6-amino-4-alkyl/aryl-3-methyl-2, 4-dihydropyrano [2, 3-c] pyrazole-5-carbonitriles in water | |
CN104356066B (zh) | 一种多取代4‑羟基吡唑类衍生物的制备方法 | |
KR100795589B1 (ko) | 2-부틸-4-클로로-1-[[2'-(1h-테트라졸-5-일)바이페닐-4-일]메틸]이미다졸-5-카르복스알데하이드의 제조방법 | |
JP2009508922A (ja) | 4−アミノピラゾール誘導体の製造方法 | |
JP2011057575A (ja) | 4−ヒドロキシベンゾチオフェン誘導体の製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 201203 Shanghai Pudong New Area China (Shanghai) Free Trade Pilot Area Zhangheng Road 1999 Building 3 Applicant after: ARIZEST (SHANGHAI) PHARMATECH Co.,Ltd. Applicant after: SHANGHAI ACEBRIGHT PHARMACEUTICALS GROUP Co.,Ltd. Address before: 201203 Building No. 10, 1999, Zhangheng Road, Zhangjiang High-tech Park, Pudong New Area, Shanghai Applicant before: Alputon Inc. Applicant before: SHANGHAI ACEBRIGHT PHARMACEUTICALS GROUP Co.,Ltd. |
|
CB02 | Change of applicant information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220908 Address after: 226200 No.3 Jiangfeng Road, Qidong life and Health Industrial Park, Nantong City, Jiangsu Province Patentee after: JIANGSU XIDI PHARMACEUTICAL Co.,Ltd. Patentee after: ARIZEST (SHANGHAI) PHARMATECH Co.,Ltd. Patentee after: SHANGHAI ACEBRIGHT PHARMACEUTICALS GROUP Co.,Ltd. Address before: 201203 Shanghai Pudong New Area China (Shanghai) Free Trade Pilot Area Zhangheng Road 1999 Building 3 Patentee before: ARIZEST (SHANGHAI) PHARMATECH Co.,Ltd. Patentee before: SHANGHAI ACEBRIGHT PHARMACEUTICALS GROUP Co.,Ltd. |
|
TR01 | Transfer of patent right |